Evidence map›Paper›PMID 19018610›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2008

Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia.

Brad Spellberg, George H Talbot, Eric P Brass, John S Bradley, Helen W Boucher, David N Gilbert, Infectious Diseases Society of America

Abstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Assessment of bias in outcomes reported in trials on pneumonia: a systematic review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2014
    Pooled it
  4. Guideline
  5. Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2009
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Article
  14. Community-acquired pneumonia: similarities and differences between European and American guidelines - A narrative review.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Novel approaches are needed to develop tomorrow's antibacterial therapies.American journal of respiratory and critical care medicine · 2015
    Review
  19. The future of antibiotics.Critical care (London, England) · 2014
    Review
  20. Over-the-counter suboptimal dispensing of antibiotics in Uganda.Journal of multidisciplinary healthcare · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Brad SpellbergInfectious Diseases Society of America Antimicrobial Availability Task Force, USA. bspellberg@labiomed.org
George H Talbot
Eric P Brass
John S Bradley
Helen W Boucher
David N Gilbert
Infectious Diseases Society of America

Funding

Mechanisms of Als vaccine protection against S. aureusR01AI072052 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SPELLBERG, BRAD J · 2007 to 2011
$1.8M
Adrenergic Antagonism During Murine CandidiasisK08AI060641 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SPELLBERG, BRAD J · 2004 to 2008
$625k
NIAID NIH HHS K08 AI060641NIAID NIH HHS R01 AI072052
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Research DesignAdultAgedAged, 80 and overAnti-Bacterial AgentsClinical Trials as TopicCommunity-Acquired InfectionsHumansMiddle AgedPneumoniaTreatment OutcomeAnti-Bacterial Agents

Identifiers

PMID19018610
PMCPMC2827629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.